-
EP3818059
European procedure
Extract from the Register of European Patents
EP About this file: EP3818059
| EP3818059 - INTERMEDIATES IN THE SYNTHESIS OF C3-SUBSTITUTED CEPHALOSPORINS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 19.04.2024 Database last updated on 02.11.2024 | |
| Former | Grant of patent is intended Status updated on 19.12.2023 | ||
| Former | Request for examination was made Status updated on 14.11.2023 | ||
| Former | Grant of patent is intended Status updated on 14.09.2023 | ||
| Former | Request for examination was made Status updated on 09.04.2021 | ||
| Former | The international publication has been made Status updated on 11.01.2020 | ||
| Former | unknown Status updated on 15.07.2019 | Most recent event Tooltip | 01.11.2024 | Lapse of the patent in a contracting state New state(s): LV, RS | published on 04.12.2024 [2024/49] | Applicant(s) | For all designated states Norbrook Laboratories Limited Carnbane Industrial Estate Newry Down BT35 6QQ / GB | [2021/19] | Inventor(s) | 01 /
MADELA, Karolina c/o Norbrook Laboratories Limited Carnbane Industrial Estate Newry, Down BT35 6QQ / GB | [2021/19] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2024/21] |
| Former [2021/19] | HGF 1 City Walk Leeds LS11 9DX / GB | Application number, filing date | 19736478.9 | 02.07.2019 | [2021/19] | WO2019GB51871 | Priority number, date | GB20180010849 | 02.07.2018 Original published format: GB 201810849 | [2021/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020008183 | Date: | 09.01.2020 | Language: | EN | [2020/02] | Type: | A1 Application with search report | No.: | EP3818059 | Date: | 12.05.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.01.2020 takes the place of the publication of the European patent application. | [2021/19] | Type: | B1 Patent specification | No.: | EP3818059 | Date: | 22.05.2024 | Language: | EN | [2024/21] | Search report(s) | International search report - published on: | EP | 09.01.2020 | Classification | IPC: | C07D463/22, C07D307/16 | [2021/19] | CPC: |
C07D463/22 (EP);
C07D501/08 (GB);
C07D501/10 (US);
C07D307/16 (EP,US);
C07C45/676 (GB)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/19] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ZWISCHENPRODUKTE ZUR SYNTHESE VON C3-SUBSTITUIERTEN CEPHALOSPORINEN | [2021/19] | English: | INTERMEDIATES IN THE SYNTHESIS OF C3-SUBSTITUTED CEPHALOSPORINS | [2021/19] | French: | INTERMÉDIAIRES UTILISÉS DANS LA SYNTHÈSE DE CÉPHALOSPORINES SUBSTITUÉES EN C3 | [2021/19] | Entry into regional phase | 21.01.2021 | National basic fee paid | 21.01.2021 | Designation fee(s) paid | 21.01.2021 | Examination fee paid | Examination procedure | 21.01.2021 | Examination requested [2021/19] | 21.01.2021 | Date on which the examining division has become responsible | 24.08.2021 | Amendment by applicant (claims and/or description) | 15.09.2023 | Communication of intention to grant the patent | 13.11.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 20.12.2023 | Communication of intention to grant the patent | 12.04.2024 | Fee for grant paid | 12.04.2024 | Fee for publishing/printing paid | 12.04.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 16.06.2021 | Renewal fee patent year 03 | 04.05.2022 | Renewal fee patent year 04 | 23.06.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | BG | 22.05.2024 | LV | 22.05.2024 | NO | 22.08.2024 | RS | 22.08.2024 | GR | 23.08.2024 | IS | 22.09.2024 | [2024/49] |
| Former [2024/47] | BG | 22.05.2024 | |
| NO | 22.08.2024 | ||
| GR | 23.08.2024 | ||
| IS | 22.09.2024 | ||
| Former [2024/46] | BG | 22.05.2024 | |
| NO | 22.08.2024 | ||
| IS | 22.09.2024 | Cited in | International search | [ID]WO9201696 (BEECHAM GROUP PLC [GB]); | [A]EP1803715 (CIMEX PHARMA AG [CH], et al); | by applicant | WO9201695 | WO9201696 | GB2300856 | EP1178049 | WO0246199 | WO0246198 | WO03045435 | WO2005092900 |